This document compares the financials of Cipla and Dr. Reddy's Labs. It provides brief histories of both companies, with Cipla being founded in 1935 and Dr. Reddy's in 1984. It then gives overviews of recent developments, products, and financial metrics for both companies, including share price charts over the last year and quarterly results. In conclusion, it states that both companies are fundamentally good but stocks are high risk now due to pandemic-related price increases. It recommends Dr. Reddy's over Cipla for investment due to its more consistent past returns.

1. A Comparison between the financials
of:
Cipla
&
Dr.Reddy’s Labs
Name- Roshan
Kumar
Class Roll No- 2022

2. COMPANY PROFILE AND HISTORY

3. Cipla Ltd is one of the leading
pharmaceutical companies in
India. The company focuses on
development of new
formulations and has a wide
range of pharmaceutical
products. The product portfolio
includes over 1500 products
across wide range of
therapeutic categories.
Cipla Ltd was incorporated in the
year 1935 with the name
Chemical Industrial &
Pharmaceutical Laboratories Ltd.
Khwaja Abdul Hamied the founder
of Cipla gave the company all his
patent and proprietary formulas
for several drugs and medicines
without charging any royalty. On
August 17 1935 Cipla was

4. Cipla in 1940

5. About Cipla
 Its today's share price is 795.35. Its current market capitalisation
stands at Rs 66097.07 Cr. In the latest quarter, company has
reported Gross Sales of Rs. 135553.4 Cr and Total Income of
Rs.135729.1 Cr.
 Cipla announced its entry into the anti-fungal product category with
Clocip, a skin infection solution.
Cipla launched Cipremi, an experimental anti-viral drug remdesivir,
having Emergency Use Authorisation (EUA) treatment for adult and
paediatric patients hospitalized with suspected or laboratory
confirmed COVID-19 infection
Received approval for its Abbreviated New Drug Application (ANDA)
for Albuterol Sulfate Inhalation Aerosol 90 mcg (base)/actuation
Acquired four key brands from Wanbury for up to Rs. 89 crore (US$
12.73 million) in order to strengthen its women’s health segment

6. COMPANYPROFILEANDHISTORY

7. Dr Reddy's Laboratories Ltd (DRL) is
an integrated global pharmaceutical
company committed to providing
affordable and innovative medicines
for healthier lives. Through its three
businesses - Pharmaceutical
Services &Active Ingredients Global
Generics and Proprietary Products -
Dr. Reddy's offers a portfolio of
products and services including
Active Pharmaceutical Ingredients
(APIs) custom pharmaceutical
services generics biosimilars and
differentiated formulations
Dr Reddy's Laboratories was incorporated
in the year 1984 in Hyderabad. The
company was established by Dr Anji
Reddy with an initial capital outlay of Rs
25 lakh. The company made their
beginning with the manufacture of Active
Pharmaceutical Ingredients and
Intermediates (API) and commenced
operations with a single drug in a 60-

9. CIPLA

10. CIPLA
This is the weekly chart showing the share price of cipla
for last 1 year

11. Cashflow statements of
Cipla

12. Balance sheet data of cipla

15. Quarterly Results

17. REDDY’s LTD.
FINACIAL STATEMENT &
RATIO ANALYSIS.

18. Dr.Reddy’s

19. This is the weekly chart showing the share price of cipla for
last 1 year

20. Cashflow statements of
Dr.Reddys

21. Balance sheet data of Dr.
Reddy’s

24. Quarterly Results

26. Conclusion
 Both the companies are good fundamentally but
given the rise that we have seen in pharma
stocks after the pandemic ,the pharma stocks are
availaible at a very high price to invest in. As the
stock price is high there is more risk involved in
investing these stocks with less returns .
 But if I have to choose between these two stocks
I would rather choose Dr.Reddy’s over cipla as it
has given a consistent return as compared to
cipla , so dr reddy may prove a good investment
in long term.

27. Thank
You!